ACE and triple-A syndrome: On the other hand, statins and ACE inhibitors should be considered because of the potential benefits to cardiovascular disease, but these drugs should not to be used for the sole purpose of reducing the risk of AAA expansion and rupture (weak level of recommendation) [8].